摘要
胸腺肽α1是从胸腺素第5组分中分离纯化出的一种小分子生物活性多肽。近年来,胸腺肽α1开始用于慢性乙型病毒性肝炎和慢性丙型病毒性肝炎的治疗,其耐受性较好,可能成为一种较好的治疗药物。但是,由于胸腺肽α1治疗肝炎相关数据的缺乏,使得人们对其治疗作用及作用机制还不太明确。鉴于此,本文对胸腺肽α1在病毒性肝炎抗病毒治疗中的应用进行综述。
Thymosin α1 is a small molecule bioactive peptide which isolated from thymosin fraction 5.In recent years,thymosin α1 has begun to be used in treating chronic viral hepatitis B and chronic viral hepatitis C.As shown by the outcome of a better tolerance,thymosin α1 may become a better drug in treating viral hepatitis with wide range of clinical applications.However,due to lack of data of thymosin α1 in clinical treatment,its therapeutic effect and mechanism are still not very clear.The article reviewed recent applications of thymosin α1 in treating viral hepatitis.
出处
《实用药物与临床》
CAS
2010年第2期135-137,共3页
Practical Pharmacy and Clinical Remedies
关键词
胸腺肽Α1
慢性乙型肝炎
慢性丙型肝炎
Thymosin α1
Chronic viral hepatitis B
Chronic viral hepatitis C
